A detailed history of Avantax Advisory Services, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 226,200 shares of MRK stock, worth $22.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
226,200
Previous 227,221 0.45%
Holding current value
$22.2 Million
Previous $28.1 Million 8.68%
% of portfolio
0.17%
Previous 0.2%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $113,484 - $131,678
-1,021 Reduced 0.45%
226,200 $25.7 Million
Q2 2024

Aug 09, 2024

BUY
$123.8 - $132.96 $11 Million - $11.8 Million
88,756 Added 64.1%
227,221 $28.1 Million
Q1 2024

May 08, 2024

BUY
$113.24 - $131.95 $2.52 Million - $2.94 Million
22,289 Added 19.19%
138,465 $18.3 Million
Q4 2023

Feb 07, 2024

BUY
$100.18 - $109.02 $493,987 - $537,577
4,931 Added 4.43%
116,176 $12.7 Million
Q3 2023

Nov 07, 2023

SELL
$102.95 - $114.33 $1.42 Million - $1.57 Million
-13,767 Reduced 11.01%
111,245 $11.5 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $439,218 - $478,728
4,044 Added 3.34%
125,012 $14.4 Million
Q1 2023

Apr 28, 2023

BUY
$102.94 - $114.86 $233,570 - $260,617
2,269 Added 1.91%
120,968 $12.9 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $76,684 - $98,320
-877 Reduced 0.73%
118,699 $13.2 Million
Q3 2022

Nov 01, 2022

BUY
$84.53 - $94.96 $789,679 - $887,116
9,342 Added 8.47%
119,576 $10.3 Million
Q2 2022

Aug 02, 2022

BUY
$83.49 - $94.64 $1.43 Million - $1.62 Million
17,117 Added 18.38%
110,234 $10.1 Million
Q1 2022

Apr 27, 2022

SELL
$73.51 - $82.4 $64,909 - $72,759
-883 Reduced 0.94%
93,117 $7.63 Million
Q4 2021

Jan 24, 2022

BUY
$72.28 - $90.54 $565,229 - $708,022
7,820 Added 9.07%
94,000 $7.2 Million
Q3 2021

Oct 21, 2021

BUY
$71.68 - $78.83 $499,394 - $549,208
6,967 Added 8.8%
86,180 $6.5 Million
Q2 2021

Jul 29, 2021

BUY
$70.31 - $77.77 $443,374 - $490,417
6,306 Added 8.65%
79,213 $6.17 Million
Q1 2021

May 13, 2021

BUY
$68.86 - $81.11 $313,795 - $369,618
4,557 Added 6.67%
72,907 $5.63 Million
Q4 2020

Jan 22, 2021

SELL
$71.77 - $79.65 $4.35 Million - $4.83 Million
-60,590 Reduced 46.99%
68,350 $5.58 Million
Q3 2020

Oct 14, 2020

BUY
$73.18 - $82.95 $4.26 Million - $4.83 Million
58,179 Added 82.22%
128,940 $10.7 Million
Q2 2020

Aug 06, 2020

BUY
$70.42 - $80.13 $344,987 - $392,556
4,899 Added 7.44%
70,761 $5.47 Million
Q1 2020

Apr 30, 2020

BUY
$63.36 - $87.82 $548,254 - $759,906
8,653 Added 15.13%
65,862 $5.08 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $1.2 Million - $1.35 Million
15,439 Added 36.96%
57,209 $5.2 Million
Q3 2019

Nov 08, 2019

BUY
$76.08 - $82.93 $690,730 - $752,921
9,079 Added 27.77%
41,770 $3.51 Million
Q2 2019

Aug 06, 2019

BUY
$69.84 - $81.59 $389,916 - $455,516
5,583 Added 20.6%
32,691 $2.74 Million
Q1 2019

May 13, 2019

BUY
$69.58 - $79.36 $82,382 - $93,962
1,184 Added 4.57%
27,108 $2.26 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $1.69 Million - $1.96 Million
25,924 New
25,924 $2 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.